tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PCRX is currently covered by 4 analysts with an average price target of $36.29. This is a potential upside of $10.56 (41.04%) from yesterday's end of day stock price of $25.73.
Pacira Pharmaceuticals's activity chart (see below) currently has 333 price targets and 254 ratings on display. The stock rating distribution of PCRX is 22.22% HOLD and 77.78% BUY.
Analysts average stock forecasts to be materialized ratio is 66.66% with an average time for these price targets to be met of 308.6 days.
Highest price target for PCRX is $65, Lowest price target is $18, average price target is $37.75.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 17-Nov-2025. First documented stock forecast 18-Jan-2013.
Currently out of the existing stock ratings of PCRX, 2 are a HOLD (22.22%), 7 are a BUY (77.78%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$38
$14.43 (61.22%)
25 days ago
(17-Nov-2025)
4/5 (80%)
$14.22 (59.80%)
889
Buy
$30
$6.43 (27.28%)
$32
7 months 3 days ago
(09-May-2025)
4/21 (19.05%)
$4.88 (19.43%)
496
Buy
$65
$41.43 (175.77%)
$70
8 months 4 days ago
(08-Apr-2025)
13/29 (44.83%)
$38.73 (147.43%)
233
Hold
$18
$-5.57 (-23.63%)
$18
10 months 28 days ago
(14-Jan-2025)
1/11 (9.09%)
$-2.55 (-12.41%)
11
Hold
$17
$-6.57 (-27.87%)
$25
1 years 1 months ago
(12-Nov-2024)
4/12 (33.33%)
$0.2 (1.19%)
270
What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?
